Baxter Issues Voluntary Nationwide Recall for One Lot of 70% Dextrose Injection Due to Potential Presence of Particulate Matter
- Date
- Aug 25, 2026
- Company
- Baxter International Inc.
- Brand
- Baxter
- Product
- 70% Dextrose Injection, USP in 2000 mL VIAFLEX Plastic Container
- Reason
- Potential presence of particulate matter identified as stainless steel particles in the solution.
- Hazard
- Other
- Source
- FDA
How to identify the product
- (NYSE:BAX) is voluntarily recalling one lot of 70% Dextrose Injection due to the potential presence of particulate matter identified as stainless steel particles in the solution.
- The affected lot can be identified by locating the lot number and expiration date on the individual product and shipping carton, as shown in the images below.
- The impacted product was distributed from 7/25/2026 to 7/28/2026 to healthcare providers and distributors to select states in the United States, including Alabama, Georgia, and Tennessee.
- Customers should immediately discontinue use of and return all affected units in accordance with their facility’s process.
- Homecare facilities who used this lot to compound parenteral nutrition solutions should contact their patients to alert them to discontinue using the solutions and replace them with ones not compounded with the affected lot.
- Baxter is contacting customers by email with instructions on how to identify and return the impacted product.
Product photos are on the official FDA page.
Facts are taken from the official notice. If anything here differs from it, the official notice is correct.